(a) Purified PANX1 protein was cleaved in vitro by caspase 3 (Casp3). Coomassie Blue stained gel showed fulllength PANX1 (~48 kDa), and caspase-cleaved PANX1 (~42 kDa). Immunoblot probed with anti-histidine antibody showed diminished signal for Casp3-cleaved PANX1 due to removal of the C-terminal histidine tag. Size-exclusion chromatographs (middle) and fluorescent thermal stability assay (right) showed both purified full-length PANX1 (blue) and (2x) and monomeric (1x) forms of 3(2CT)-GFP were found in cross-linked and cell-surface biotinylated samples, supporting hexameric channel conformation of PANX1 at the cell surface. HEK293T cells expressing 3(2CT)-GFP were first labeled with membrane impermeable biotin, followed by exposure to the membrane permeable crosslinker, DSS. Biotinylated proteins were precipitated using streptavidin-agarose beads and detected with anti-GFP antibody. (c) Representative cell-surface biotinylation assay (from n=3) showed that the full-length monomeric and the concatenated PANX1 channels, 2(0CT), 2(1CT), and 3(2CT), were expressed at the cell surface, primarily at the predicted molecular weights (~80, ~90, or ~140 kDa). PANX1 concatemers were detected with anti-FLAG antibody. Left: FLAG-tagged PANX1 concatemers from streptavidin-pulldown samples. Right: FLAG-tagged PANX1 concatemers from total cell lysates. Note that although proteins with size of ~100 kDa were detected in 3(2CT)-expressing cells, the larger ~140-kDa protein was predominantly expressed at the cell surface. (d) Dimeric and trimeric PANX1 concatemers are glycosylated. HEK293T cells were transiently transfected with 2(0CT), 2(2CT), or 3(2CT), and whole cell lysates were treated with 50% glycerol or PNGase F (7000 U·mg -1 ), followed by SDS-PAGE analysis using anti-FLAG antibodies to detect concatemers.
Supplementary Figure 3. Hexameric PANX1 concatemers are glycosylated and expressed at the cell surface
(a) Schematic shows a panel of hexameric PANX1 concatemers containing varying number of full-length or Cterminally-truncated subunits. (b) Representative cell-surface biotinylation (from n=3) showed all hexameric PANX1 concatemers are expressed at the cell surface at their predicted molecular weights (from ~240-300 kDa). PANX1 concatemers were detected with anti-FLAG antibody. Upper: FLAG-tagged PANX1 concatemers from streptavidin-pulldown samples. Lower: FLAG-tagged PANX1 concatemers from whole cell lysates. Note that the lower molecular weight proteins found in total cell lysates were not detected in streptavidin-pulldown samples. (c) Expression of 6(1CT)-GFP and 6(6CT)-GFP in HEK293T cells, with or without TEVp co-expression. Bright field (left) and fluorescent (right) images were taken using 63x Axio Imager 2. Green: GFP-tagged PANX1 concatemers. Blue: cell nuclei stained by Hoechst 33342. Scale bar: 10 m. (d) Hexameric PANX1 concatemers are glycosylated. HEK293T cells were transiently transfected with 6(1CT) or 6(6CT), followed by exposure to membraneimpermeable biotin; cells were then lysed, and cell lysates were treated with 50% glycerol or PNGase F (7000 U·mg -1 ), followed by streptavidin pull-down. Upper: FLAG-tagged PANX1 concatemers from streptavidin pulldown samples. Lower: FLAG-tagged PANX1 concatemers from whole cell lysates. (a) ATP release from HEK293T cells expressing GFP-tagged hexameric PANX1 concatemers, with or without TEVp co-expression. Cells were incubated in assay buffer containing ARL67156 (300 µM) for 8 h, with either DMSO (white) or trovafloxacin (Trovan, 25 M, black). Vertical double arrows (blue) indicate PANX1-dependent (i.e., Trovan-sensitive) ATP release. Red dashed line represents trend of background ATP release (i.e., Trovaninsensitive and PANX1-independent). Note that increasing background ATP accumulation was observed with more active hexameric constructs under these conditions, likely reflecting cell death, and making this longer time point unreliable for quantitative comparisons across all constructs. (b) TO-PRO-3 uptake for 15, 30, or 60 min in Jurkat cells expressing GFP-tagged hexameric PANX1 concatemers. Cells were co-expressed with (blue) or without (black) TEVp. Red dash lines depict the averaged TO-PRO-3 uptake from cells without TEVp co-expression. Data are presented as mean ± s.e.m. from two independent experiments. *: P<0.05 using two-way ANOVA followed by Fisher's LSD test; n.s.: no statistical significance. 
Supplementary Figure 8. α1DR-mediated activation of PANX1 channels
(a) Whole-cell recordings obtained from HEK293T cells heterologously expressing α1D adrenoceptor (α1DR) along with FLAG-tagged full-length PANX1 or PANX1(TEV). Left: whole-cell PANX1 current (at +80 mV) was increased by phenylephrine (PE, 20 µM) and inhibited by CBX (50 µM). Middle: I-V relationships under control conditions (Ctrl, black), during phenylephrine stimulation (PE, blue) and after CBX inhibition (brown). Right: averaged current density induced by PE is 14.7 ± 2.0 pA/pF for full-length PANX1 (n=6), and 12.6 ± 4.4 pA/pF for PANX1(TEV) (n=3). Note that PANX1(TEV) is caspase-cleavage resistant. (b) Increased activity of five α1DR-activated PANX1 channels after removing CBX inhibition (from the same patch shown in Fig. 6c ). (c) Examples of PE-activated PANX1 channels with small conductance (~27 pS for left and ~15 pS for right) obtained from different patches at +80 and +60 mV by cell-attached recording. (d) Examples of cell-attached recordings during PE stimulation from a HEK293T cell expressing α1DR and GFP-tagged full-length PANX1. Single-channel activity shows gradually increased single-channel current amplitude at +50 mV over the initial period of PE stimulation (from left to right). (e) Cell-attached recording of steady-state PANX1 activation induced by PE stimulation. Exploded views from the gray-boxed 100-ms are filtered at 1 kHz (upper-right) or 5 kHz (lower-right). Reverse primer for PANX1 overlapextension PCR round 1
